eXTReMe Tracker
Gene Therapy Net RSS feed Follow Gene Therapy Net on Twitter LinkedIn - Gene Therapy Net discussion group Facebook - Gene Therapy Net

Newsletter March 2012

Gene Therapy Net Banner
News: Study shows developing a gene therapy for cancer will be harder than scientists thought
Scientists working to customize cancer treatment based on each person's genes are finding new evidence of just how tough this task will be. In a single tumor, there are big differences as to which genes are active or mutated. Nor are the genetics of a single tumor and where it has spread consistent. This means that the single biopsies that doctors rely on to choose drugs are probably not giving a true view of the cancer's biology.
Read more...

News: CHMP asks AMT to provide additional information on Glybera
Amsterdam Molecular Therapeutics (AMT), a leader in the field of human gene therapy, has received a request to provide additional information to the Committee for Human Medicinal Products (CHMP) on Glybera (alipogene tiparvovec) by March 8, 2012. The CHMP request follows the announcement on January 30, 2012 that the European Commission Standing Committee was requesting additional information from the CHMP. The CHMP has indicated that a final decision on Glybera could be made by May 2012.
Read more...

Poll: Cancer gene therapy available in China
Gene Therapy Net started a new poll regarding commercial cancer gene therapy treatments in Asia. There is still no gene therapy product on the market in the US and Europe, but there is a gene therapy cancer product available in China. Would you travel to China to receive this treatment? What do you think? Vote now!
1- Yes, immediately, or
2- Yes, but first consult my own doctor, or
3- No, I don't think it will work, or
4- No, I want treatment in my own country

Vote now...

Members Discount: Download files and save up to 33%
Gene Therapy Net members can download interesting files and receive serious discounts. For example, download all questions, answers and explanation of the Gene Therapy Multiple Choice Quiz, including basic, intermediate and advanced difficulty level. The Word file is ideal study material!
You can also download the high resolution jpg image as well as the original powerpoint file of the figure: A comparison of different viral vectors in use for gene therapy: overview of their advantages and disadvantages. The powerpoint file can be used in your own presentations or for educational purposes.

Read more...

Conferences
- 15 - 17 March 2012, 18th Annual Meeting of the German Society for Gene Therapy (DG-GT), Frankfurt/Main, Germany
- 16 – 19 May 2012, American Society of Gene and Cell Therapy (ASGCT) 15th Annual Meeting, Philadelphia, PA
- 21 – 23 May 2012, 2012 World Gene Therapy Congress Europe, London, UK
- 5 – 8 June 2012, International Society for Cellular Therapy (ISCT) 18th Annual Meeting, Seattle, WA
- 28 – 30 June 2012, The 18th Annual Meeting of the Japan Society of Gene Therapy (JSGT), Kumamoto University, Kumamoto, Japan
- 5 – 6 October 2012, International Society for Cell & Gene Therapy of Cancer - 2012 Singapore Conference, Singapore
- 22 – 24 October 2012, International conference on Genetic Syndromes & Gene Therapy, Chicago
- 26 – 29 October 2012, European Society Of Gene & Cell Therapy (ESGCT) XXth annual meeting and the French Society of Cell and Gene Therapy (SFTCG) collaborative Congress 2012, Versailles, France

Read more...

Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and the site serves as a network in the exchange of gene therapy information and breaking news items. Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, regulations and guidelines. Other information websites created and maintained by the owner of Gene Therapy Net are Dengue Virus Net, Influenza Virus Net and Chikungunya Virus Net.
To unsubscribe from the Newsletter, please login and edit your subscription details or contact us. You are currently registered as: {subtag:name}, email address: {subtag:email}.